KLOX TECHNOLOGIES INC. [●] Shares Common Shares (no par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • April 27th, 2015 • Klox Technologies, Inc. • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENTEmployment Agreement • April 27th, 2015 • Klox Technologies, Inc. • Pharmaceutical preparations
WHEREAS the Corporation has retained the services of the Executive to act as its Vice President Clinical and Medical Affairs for a start of employment date of May 4, 2015, and the Executive has accepted to offer such services to the Corporation;
DISTRIBUTION AND SUPPLY AGREEMENT BETWEEN KLOX TECHNOLOGIES INC. AND SANDOZ CANADA INC. NOVEMBER 15, 2013Distribution and Supply Agreement • January 12th, 2015 • Klox Technologies, Inc. • Pharmaceutical preparations • Quebec
This Distribution and Supply Agreement is entered into at the City of Montreal, Province of Quebec, on this 15th day of November, 2013 (the “Effective Date”) by and between:
DATED AS OF JULY 9, 2014 KLOX TECHNOLOGIES INC. - and - LEO PHARMA A/S LICENSE JOINT VENTURE AGREEMENTJoint Venture Agreement • February 11th, 2015 • Klox Technologies, Inc. • Pharmaceutical preparations
CONSULTING AND SERVICE AGREEMENTConsulting and Service Agreement • February 11th, 2015 • Klox Technologies, Inc. • Pharmaceutical preparations • Quebec
This Consulting and Service Agreement (the “Agreement,”) is made as of October 4, 2012 (the “Effective Date”), between Picchio International Inc., with a business address at 516 – 922, 5th Avenue S.W., Calgary, AB T2P 3R4 (the “Consultant”); and KLOX TECHNOLOGIES INC., with a business address at 275 Armand-Frappier Boulevard, Laval, Quebec H7V 4A7, Canada (“KLOX”) (individually, a “Party,” and collectively, the “Parties”).
KLOX TECHNOLOGIES INC. a Corporation incorporated under the laws of Canada Warrant for the Purchase of Common SharesKlox Technologies, Inc. • February 11th, 2015 • Pharmaceutical preparations • Quebec
THIS CERTIFIES that, for value received, FRANCESCO BELLINI (the “Holder”) is the registered holder of 30,460 Common Shares purchase warrants (the “Warrants”) of KLOX TECHNOLOGIES INC., (the “Corporation”). Each Warrant entitles the Holder, subject to the terms, conditions and adjustments set forth in this warrant certificate (the “Certificate”), to acquire from the Corporation, at the initial exercise price per Common Share of $5.00 (the “Exercise Price”), one fully paid and non-assessable Common Share (the “Common Shares”) in the share capital of the Corporation, as constituted on the date hereof. The number of Common Shares which the Holder is entitled to acquire upon exercise of each Warrant is subject to adjustment as hereinafter provided.
INDEMNIFICATION AGREEMENTIndemnification Agreement • March 17th, 2015 • Klox Technologies, Inc. • Pharmaceutical preparations
• as a director or officer (or another position of similar capacity) of any other entity (an “Other Entity”) to the extent that you are serving in such capacity at the request of the Corporation,
EMPLOYMENT AGREEMENTEmployment Agreement • February 11th, 2015 • Klox Technologies, Inc. • Pharmaceutical preparations
BY AND BETWEEN: KLOX TECHNOLOGIES INC., a corporation incorporated under the Canada Business Corporations Act, having its principal place of business at 275 Armand Frappier, Laval, Quebec, H7V 4A7, herein represented by Dr. Francesco Bellini, its Chairman, duly authorized as he so declares;
